Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment — BEACON

Relapsing Remitting Multiple Sclerosis (RRMS) Clinical Trial

Official title:
Betaferon Prospective Study on Adherence, Coping and Nursing Support

Status Completed

Clinical Trial Summary

- The Study analyses the influence of selected factors on adherence to Betaferon treatment in patients with early multiple sclerosis (MS). The Investigator will document the relevant medical data regarding multiple sclerosis at every hospital visit, the patient will fill in two questionnaires at every visit: one about coping with the disease and the other about anxiety and depression.

- The Study particularly looks at the role of the support of the patient given by the multiple sclerosis nurses.The nurse will provide additional standardised information at start of treatment and will regularly phone the patient to ask standardised questions about the general condition with regard to the treatment, the disease and social support. At the end of the Study it will be assessed if the supportive measures and the standards in terms of adherence management in the hospital have some influence to increase long-term treatment adherence.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Relapsing Remitting Multiple Sclerosis (RRMS)

Clinical Trial Details

NCT number	NCT00787657
Study type	Observational
Source	Bayer
Contact
Status	Completed
Phase	N/A
Start date	June 2008
Completion date	October 2014

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01499667` - Disease Control and Safety in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Switching From Natalizumab to Fingolimod	Phase 3
Completed	`NCT02035514` - Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis	Phase 1/Phase 2
Completed	`NCT00428584` - RNF and Betaseron® Tolerability Study	Phase 3
Completed	`NCT05242133` - Efficacy and Safety of Peginterferon Beta-1a (CinnaGen) in Participants With Relapsing Remitting Multiple Sclerosis	Phase 3
Completed	`NCT01125475` - A Scandinavian Non-interventional Study of Adherence to RebiSmart Administered Rebif New Formulation (RNF) Treatment in Relapsing Remitting Multiple Sclerosis (RRMS) Subjects	N/A
Completed	`NCT00871780` - A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) Patients	Phase 4
Completed	`NCT01235455` - Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors	N/A